NEW BIOPOLYMERS FOR MEDICAL APPLICATIONS

这项研究的长期目标是使用一种生物 一种名为聚合酶的催化剂，用于创建新的生物聚合物并识别 那些对生物医药行业有用的特性。具体来说， 在生物医学领域，这些新型的生物兼容材料可能是有用的 在以下方面的应用：作为抗粘连剂的外科辅助剂； 使用微胶囊控制药物输送；伤口护理作为缝线和 纱布；骨板；以及治疗靶向。研究目标 包括制备小有机分子，这些小分子可以通过 从油假单胞菌中提取长链聚合酶，转化为新的生物材料。 后者将在随后进行描述。通过筛选一个大的 一些小的有机分子，它应该可以创造许多 用于医疗行业的新型可生物降解聚酯。

The long-term objectives of this research are to use a biological catalyst known as a polymerase, to create new biopolymers and identify those with useful properties for the biomedical industry. Specifically, in the biomedical area these novel biocompatible materials may be useful in applications such as: surgical aids as anti-adhesion agents; controlled drug delivery using microcapsules; wound care as sutures and gauzes; bone plates; and therapeutic targeting. The research goals involve preparing small organic molecules which may be converted, by the long chain polymerase from Pseudomonas oleovorans, into new biomaterials. The latter will subsequently be characterized. By screening a large number of small organic molecules it should be possible to create many new biodegradable polyesters for the medical industry.